Sporopachydermia cereana fungaemia in refractory leukaemia presenting as breakthrough infection during micafungin therapy

被引:2
|
作者
Chan, T. S. Y. [1 ,2 ]
Hwang, Y-Y. [1 ,2 ]
To, K. K. [1 ,2 ]
Kwong, Y-L. [1 ,2 ]
机构
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
关键词
Sporopachydermia cereana; Micafungin; Breakthrough infection;
D O I
10.1007/s15010-012-0402-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Sporopachydermia cereana species lives in decaying stems of cactus and is exceptionally rare as a human pathogen. A 57-year-old man with therapy-refractory acute promyelocytic leukaemia developed severe neutropaenia. After about 3 weeks of micafungin used as prophylaxis, he developed high fever, multiple pulmonary nodular infiltrates and a painful leg lesion. Blood culture yielded a yeast which was not identified by the Vitek 2 system. On ITS1-5.8S-ITS2 gene sequencing, the isolate was identified as S. cereana. Antifungal sensitivity by the Etest showed that the minimum inhibitory concentration for fluconazole was 0.75 mu g/mL, and for anidulafungin, it was > 32 mu g/mL. He responded to liposomal amphotericin B but later died of Escherichia coli septicaemia. There were no cactus plants in the vicinity, suggesting that S. cereana might have alternative habitats.
引用
收藏
页码:715 / 717
页数:3
相关论文
共 29 条
  • [1] Sporopachydermia cereana fungaemia in refractory leukaemia presenting as breakthrough infection during micafungin therapy
    T. S. Y. Chan
    Y.-Y. Hwang
    K. K. To
    Y.-L. Kwong
    [J]. Infection, 2013, 41 : 715 - 717
  • [2] Breakthrough disseminated cryptococcosis during micafungin therapy
    Lee, Wen-Sen
    Hsieh, Tai-Chin
    Ou, Tsong-Yih
    Teng, Sing-On
    Chen, Fu-Lun
    Wang, Fu-Der
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2015, 48 (04) : 456 - 458
  • [3] Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients
    Spanik, S
    Trupl, J
    Kunova, A
    Drgona, L
    Salek, T
    Mardiak, J
    Kukuckova, E
    Studena, M
    Pichna, P
    Oravcova, E
    Grey, E
    Koren, P
    Svec, J
    Lacka, J
    Sufliarsky, J
    Krcmery, V
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1997, 46 (06) : 517 - 523
  • [4] Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia
    Rieger, C.
    Geiger, S.
    Herold, T.
    Nickenig, C.
    Ostermann, H.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (11) : 843 - 845
  • [5] Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia
    C. Rieger
    S. Geiger
    T. Herold
    C. Nickenig
    H. Ostermann
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 843 - 845
  • [6] Breakthrough Exophiala dermatitidis infection during prophylactic administration of micafungin during second umbilical cord blood transplantation after graft failure
    Watanabe, Naoki
    Gotoh, Akihiko
    Shirane, Shuichi
    Hamano, Yasuharu
    Hirai, Yuji
    Shimizu, Maika
    Nakamura, Ayako
    Matsumoto, Kana
    Morita, Kunihiko
    Mori, Takeshi
    Ohsaka, Akimichi
    Komatsu, Norio
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (02)
  • [7] Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections
    Cattaneo, Chiara
    Panzali, Annafranca
    Passi, Angela
    Borlenghi, Erika
    Lamorgese, Cinzia
    Petulla, Marta
    Re, Alessandro
    Caimi, Luigi
    Rossi, Giuseppe
    [J]. MYCOSES, 2015, 58 (06) : 362 - 367
  • [8] Breakthrough pneumonia, meningitis and bloodstream infection due to Streptococcus pneumoniae during cefixime therapy
    Carannante, Novella
    Pallotto, Carlo
    Bernardo, Mariano
    Mallardo, Enza
    Di Caprio, Giovanni
    Palmiero, Giulia
    Attanasio, Vittorio
    Tascini, Carlo
    [J]. JOURNAL OF CHEMOTHERAPY, 2019, 31 (05) : 290 - 293
  • [9] Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome
    Krcmery, V
    Oravcova, E
    Spanik, S
    Mrazova-Studena, M
    Trupl, J
    Kunova, A
    Stopkova-Grey, K
    Kukuckova, E
    Krupova, I
    Demitrovicova, A
    Kralovicova, K
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (03) : 373 - 380
  • [10] Magnusiomyces capitatus Peritonitis in a Child With Acute Lymphocytic Leukemia as a Breakthrough Infection During Caspofungin Therapy
    Baris, Ayse
    Gencer, Hasim
    Dalgic, Nazan
    Sik, Guntulu
    Ozakkas, Fatma
    Aktas, Elif
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (12) : E351 - E353